- NICE's Dillon: Value-based pricing deadline 'very tight'
- Mens rea proof may be key to Daiichi legal action against Singh bros amid war of words
- BIO 2013: Looking for the transformation booth
- ACC PREVIEW: What drug trials will be hot in Washington DC?
COMMENT Other Informa Comment